Clinical trial / 1978
Smoking cessation advice improved bronchitis symptoms and slowed ventilatory decline, but did not significantly alter blood pressure, ECG, or mortality.
A randomised controlled trial evaluated the effect of doctor-led smoking cessation advice in 1,445 middle-aged men at high cardiorespiratory risk. After one year, 51% of the 714 intervention men reported not smoking cigarettes. Compared to the normal care group, intervention men demonstrated a decline in sputum production and dyspnoea, and ventilatory function decline was significantly slowed. However, no evident effects were observed on blood pressure, 3-year ECG findings, or 1-year sickness absence. Over an average 7.9-year follow-up, 98 (13.7%) intervention participants and 94 (12.9%) normal care participants died (95% CI: 2.63% in favour of intervention to 4.37% in favour of normal care). The authors noted trial power was reduced by smoking cessation in the normal care group.
- Study type
- Randomised controlled trial
- Who was studied
- 1,445 male smokers aged 40-59 at high risk of cardiorespiratory disease
- What was measured
- Smoking cessation, respiratory symptoms/function, BP, ECG findings, mortality
THE PAPER
A randomised controlled trial of the effect on middle-aged men of advice to stop smoking.
Rose G, Hamilton PJ. J Epidemiol Community Health (1978), 1978.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.